Metabolic Ledger

Fibre on GLP-1 Drugs: Managing Constipation and Supporting Gut Health Through Diet

By Editorial TeamUpdated May 28, 2026
This article is awaiting registered-dietitian review. Information is editorial only and not a substitute for individual dietary advice. Our review process.
A teal sheaf of fibre strands with one orange strand, illustrating dietary fibre on GLP-1 drugs.
Fibre is the quiet lever for the gut side effects.

Why fibre matters more than usual on GLP-1 therapy

GLP-1 receptor agonists slow gastric emptying as part of their mechanism of action — food moves from stomach to intestine more slowly, which enhances satiety. The same slowing effect extends throughout the GI tract, reducing bowel transit time and increasing the risk of constipation.

Combined with a significantly reduced overall food intake (less bulk material in the bowel), most patients on GLP-1 therapy experience some degree of constipation, particularly during dose escalation. Constipation affects approximately 10–25% of patients on semaglutide and tirzepatide in clinical trials — second only to nausea as the most common GI side effect.

Unlike nausea, which typically improves after dose stabilisation, constipation on GLP-1 therapy often persists or worsens with dose increases. Dietary fibre is the foundational management strategy.


The two types of fibre and what they do

Dietary fibre is not a single thing. The two broad categories have different mechanisms:

Soluble fibre dissolves in water to form a gel. It slows digestion, reduces cholesterol absorption, and feeds gut bacteria. Key sources: oats, apples, legumes, chia seeds, psyllium husk.

Insoluble fibre does not dissolve. It adds bulk to stool and accelerates intestinal transit — the relevant mechanism for constipation management. Key sources: wheat bran, vegetables (particularly cruciferous), wholegrains, nuts.

For GLP-1-induced constipation, insoluble fibre is the primary target. Psyllium husk (the active ingredient in Metamucil) is technically classified as soluble but behaves more like insoluble in its laxative effect — it increases stool bulk and water content and is well-evidenced for constipation management.


The complication: high-fibre foods worsen early GLP-1 nausea

The practical tension: vegetables, legumes, and wholegrains — the main fibre sources — are often the foods GLP-1 patients find hardest to eat during nausea phases. Cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) cause bloating and gas, which is particularly unpleasant when gastric emptying is already slow.

The practical approach is phased:

Phase 1 (first 4–8 weeks, dose escalation): Tolerate fibre gaps. Focus on protein and caloric adequacy first. Do not force cruciferous vegetables if nausea is active. Use psyllium husk in water or juice as a low-volume fibre supplement — it is better tolerated than food-based fibre when GI symptoms are present.

Phase 2 (dose stabilisation): Reintroduce fibre-dense foods gradually. Cooked vegetables are better tolerated than raw. Legumes can be reintroduced — start with lentils (lowest gas production) before chickpeas or beans.

Phase 3 (maintenance): Aim for the 25–38 g/day recommended fibre intake from whole foods, supplemented with psyllium if dietary fibre alone is insufficient.


Practical fibre targets and sources

Recommended daily fibre: women 25 g/day; men 38 g/day.

Well tolerated on GLP-1:

FoodServingFibre
Oat bran30 g (dry)7 g
Chia seeds28 g (2 tbsp)10 g
Lentils (cooked)200 g16 g
Avocado½ medium5 g
Psyllium husk1 tsp (5 g)4 g
Almonds30 g3.5 g

Often problematic — introduce cautiously:

FoodServingFibreIssue
Broccoli (raw)100 g2.6 gGas, bloating
Brussels sprouts100 g3.8 gHigh gas
Beans (black, kidney)100 g cooked6–8 gGas; slow to tolerate

Psyllium husk as a fibre supplement

Psyllium is the most evidence-backed supplement for constipation management. It works by absorbing water in the colon and increasing stool bulk and softness without causing fermentation gas.

How to use: 1–2 teaspoons (5–10 g) in 250 ml of water, once or twice daily. It must be taken with adequate water — psyllium that is not adequately hydrated can worsen constipation or cause oesophageal obstruction.

Timing: Take at least 2 hours away from medications, as psyllium can reduce absorption of some drugs.

Do not use during active nausea. The gel-forming texture is poorly tolerated when GI symptoms are present.


The water-fibre interaction

Dietary fibre works only when adequately hydrated. Insoluble fibre increases stool bulk by binding water — if systemic dehydration is present, fibre can worsen constipation. The practical rule: increase fibre intake only alongside increased water intake. The 2–2.5 litres/day fluid target is even more important for patients managing constipation with dietary fibre.


When dietary fibre is not enough

If adequate fibre intake (25+ g/day) and good hydration do not resolve constipation within 1–2 weeks:

First-line: Osmotic laxatives (polyethylene glycol / Macrogol / MiraLax). These draw water into the colon and soften stool. They are safe, non-habit-forming, and appropriate for ongoing use.

Second-line: Magnesium glycinate supplementation (200–400 mg at night). Magnesium has an osmotic laxative effect and is often deficient in GLP-1 patients.

Avoid for regular use: Stimulant laxatives (senna, bisacodyl) — they can cause dependence. Appropriate for short-term use only.

If constipation is severe and unresponsive, inform the prescriber — dose reduction or hold may be indicated.


Summary

GLP-1-induced constipation is mechanistic — slow gastric emptying and reduced food volume predictably reduce bowel transit. Dietary fibre, particularly insoluble fibre and psyllium husk, is the foundational management strategy, but must be introduced gradually and implemented alongside adequate hydration. Osmotic laxatives are the appropriate step-up when dietary fibre is insufficient.


This article is queued for review by a registered dietitian. It should not be used as personal nutrition advice.

Know when things change.

We track FDA enforcement actions, compounding pharmacy status, and manufacturer pricing weekly. When something shifts that affects your treatment, you'll hear about it. Free — plus the GLP-1 Decision Aid PDF on sign-up.

We don’t share or sell your email. Unsubscribe anytime in one click. See our privacy policy.